Menopause Research Act of 2022

Bill 117 hr 8774, also known as the Menopause Research Act of 2022, is a piece of legislation introduced in the US Congress with the aim of addressing the lack of research and understanding surrounding menopause and its impact on women's health. The bill seeks to allocate funding for research into the causes and effects of menopause, as well as potential treatments and therapies to alleviate symptoms.

Specifically, the Menopause Research Act of 2022 calls for the establishment of a dedicated research program within the National Institutes of Health (NIH) to focus on menopause-related issues. This program would be tasked with conducting studies on the hormonal changes that occur during menopause, the long-term health consequences of menopause, and potential interventions to improve women's quality of life during this stage of life.

In addition to funding research, the bill also aims to raise awareness about menopause and its impact on women's health. It calls for the development of educational materials and resources for healthcare providers and the general public to increase understanding and promote better care for women experiencing menopause. Overall, the Menopause Research Act of 2022 represents a bipartisan effort to address a significant gap in women's health research and provide support for women going through menopause. By allocating resources to study this important stage of life, the bill has the potential to improve the quality of care and treatment options available to women experiencing menopause.